iopromide has been researched along with Cirrhosis, Liver in 5 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To define the percentage of small (≤2 cm) hepatocellular carcinoma (HCC) nodules showing the diagnostic enhancement pattern at CEUS, computed tomography (CT), and gadobenate dimeglumine (Gd-BOPTA)-enhanced magnetic resonance (MR) imaging." | 3.79 | Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. ( Angileri, R; Cabibbo, B; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E, 2013) |
| "Most patients with HCC have coexisting liver cirrhosis (LC) at the time of diagnosis." | 1.37 | Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. ( Bae, EJ; Chang, SH; Cho, HS; Kang, Y; Kim, HJ; Park, DJ; Seo, JW, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, GS | 1 |
| Feng, GL | 1 |
| Li, JP | 1 |
| Xu, HL | 1 |
| Wang, H | 1 |
| Cheng, YP | 1 |
| Yan, LL | 1 |
| Jiang, HJ | 1 |
| Sauter, AW | 1 |
| Spira, D | 1 |
| Schulze, M | 1 |
| Horger, MS | 1 |
| Quaia, E | 1 |
| De Paoli, L | 1 |
| Angileri, R | 1 |
| Pizzolato, R | 1 |
| Cabibbo, B | 1 |
| Cova, MA | 1 |
| Li, R | 1 |
| Cai, P | 1 |
| Ma, KS | 1 |
| Ding, SY | 1 |
| Guo, DY | 1 |
| Yan, XC | 1 |
| Cho, HS | 1 |
| Seo, JW | 1 |
| Kang, Y | 1 |
| Bae, EJ | 1 |
| Kim, HJ | 1 |
| Chang, SH | 1 |
| Park, DJ | 1 |
5 other studies available for iopromide and Cirrhosis, Liver
| Article | Year |
|---|---|
Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Hepatocellular; Case-Control Studies; C | 2017 |
Explanations for the heterogeneity of splenic enhancement derived from blood flow kinetic measurements using dynamic contrast-enhanced CT (DCE-CT).
Topics: Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Blood Volume; Contrast Media; Female; Humans; I | 2014 |
Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Im | 2013 |
Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagn | 2016 |
Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Topics: Acute Kidney Injury; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media | 2011 |